- Home
- LCNB vs SOPH Comparison
LCNB vs SOPH Comparison
Compare LCNB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- SOPH
- Stock Information
- Founded
- LCNB 1877
- SOPH 2011
- Country
- LCNB United States
- SOPH Switzerland
- Employees
- LCNB N/A
- SOPH N/A
- Industry
- LCNB Major Banks
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LCNB Finance
- SOPH Health Care
- Exchange
- LCNB Nasdaq
- SOPH Nasdaq
- Market Cap
- LCNB 216.4M
- SOPH 206.6M
- IPO Year
- LCNB N/A
- SOPH 2021
- Fundamental
- Price
- LCNB $14.52
- SOPH $3.12
- Analyst Decision
- LCNB
- SOPH Strong Buy
- Analyst Count
- LCNB 0
- SOPH 3
- Target Price
- LCNB N/A
- SOPH $7.00
- AVG Volume (30 Days)
- LCNB 23.6K
- SOPH 95.1K
- Earning Date
- LCNB 04-29-2025
- SOPH 03-04-2025
- Dividend Yield
- LCNB 6.03%
- SOPH N/A
- EPS Growth
- LCNB N/A
- SOPH N/A
- EPS
- LCNB 0.97
- SOPH N/A
- Revenue
- LCNB $79,237,000.00
- SOPH $65,173,000.00
- Revenue This Year
- LCNB N/A
- SOPH $16.63
- Revenue Next Year
- LCNB $7.21
- SOPH $26.11
- P/E Ratio
- LCNB $15.05
- SOPH N/A
- Revenue Growth
- LCNB 13.71
- SOPH 4.49
- 52 Week Low
- LCNB $12.42
- SOPH $2.70
- 52 Week High
- LCNB $17.92
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- LCNB 41.94
- SOPH 40.93
- Support Level
- LCNB $14.35
- SOPH $3.01
- Resistance Level
- LCNB $15.22
- SOPH $3.48
- Average True Range (ATR)
- LCNB 0.42
- SOPH 0.28
- MACD
- LCNB -0.04
- SOPH -0.07
- Stochastic Oscillator
- LCNB 22.86
- SOPH 9.76
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.